Teaching NeuroImage: Mobile Hypopyon as a Clinical Clue for the Diagnosis of Behçet Disease
Citation Manager Formats
Make Comment
See Comments

A 29-year-old man presented with subacute new-onset headache, confusion, and hallucinations. On examination, he had obtundation and bilateral decreased visual acuity. Brain MRI revealed a T2/fluid-attenuated inversion recovery (FLAIR) hyperintense signal of the diencephalon and basal ganglia. Subsequently, he developed anterior uveitis with mobile hypopyon (Figure). Further questioning of his wife disclosed previous episodes of “red eyes,” acne-like skin lesions, and oral ulcers.
External eye photograph depicts the mobile hypopyon (black arrow) and its movement within the anterior chamber right after the patient changed the position from standing to right lateral decubitus (curved arrow) (A). Brain MRI axial FLAIR-weighted image shows confluent hyperintense lesions in the diencephalon (B).
He was diagnosed with Behçet disease (BD) and fully recovered after a methylprednisolone pulse. The hallmarks of BD are oral and genital ulcers and uveitis. Neuro-BD often presents with cerebral venous thrombosis, aseptic meningitis, or mesodiencephalic venulitis. Although confluent diencephalic lesions on neuroimaging strongly indicate Neuro-BD, the diagnosis also relies on clinical findings.1 Hypopyon is the sedimentation of leukocytes in the anterior chamber of the eye, which manifests as a whitish fluid level. Mobile hypopyon is typical of NB and a relevant diagnostic clue.2
Study Funding
The authors report no targeted funding.
Disclosure
The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures.
Submitted and externally peer reviewed. The handling editor was Whitley Aamodt, MD, MPH.
Teaching slides links.lww.com/WNL/C476
- Received July 4, 2022.
- Accepted in final form October 6, 2022.
- © 2022 American Academy of Neurology
References
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
- No related articles found.